| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Menu Philippe serves as a Chief Medical Officer at SOPH. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $1.9M at current prices.
The biggest single holding is SOPH (~$1.9M) as Chief Medical Officer. The recent filings there lean toward selling, a net 18,125 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | SOPH Sophia Genetics SA | Chief Medical Officer | Sell | 5,000 | $5.70 | $28,505.00 | -2.1% | - | - | |
| May 26, 2026 | SOPH Sophia Genetics SA | Chief Medical Officer | Sell | 5,000 | $4.95 | $24,774.00 | -2.0% | - | - | |
| Apr 13, 2026 | SOPH Sophia Genetics SA | Chief Medical Officer | Sell | 8,125 | $4.73 | $38,403.68 | -1.0% | +16.5% | - |